Journal of Traditional Chinese Medicine >
Huoxue Jiedu Huayu recipe (活血解毒化瘀方) alleviates contralateral renal fibrosis in unilateral ureteral obstruction rats by inhibiting the transformation of macrophages to myofibroblast
Received date: 2022-05-18
Accepted date: 2022-09-14
Online published: 2023-01-10
Supported by
Effect of Macrophage-to-Myofibroblast Transition in Contralateral Kidney of Unilateral Ureteral Obstruction Rats Through the Aldosterone/ MR/SGK1 Pathway and Inhibition of Chinese Herbs(81873251);Aldosterone-induced Macrophage Polarization-lymphatic Endothelial Cell-like Trans-formation Involved in Renal Fibrosis and the Protective Effect of Yiqi Jiedu Huayu Herbs(82205006);Mechanism of Renal Fibrosis Induced by NF-kB/IL-8 Induced MMT in UUO Rats(BJK2022004)
Yunzhao XIONG , Lingjin LIU , Ziqian LIU , Gege CHEN , Juan HAO , Xiaomeng GAO , Panpan QIANG , Zheng WANG , Qingyou XU . Huoxue Jiedu Huayu recipe (活血解毒化瘀方) alleviates contralateral renal fibrosis in unilateral ureteral obstruction rats by inhibiting the transformation of macrophages to myofibroblast[J]. Journal of Traditional Chinese Medicine, 2023 , 43(1) : 105 -112 . DOI: 10.19852/j.cnki.jtcm.2023.01.009
| 1 | Chung EYM, Strippoli GFM. Aldosterone antagonists in addition to renin angiotensin system antagonists for preventing the progression of CKD: editorial summary of a cochrane review. Am J Kidney Dis 2021; 77: 810-12. |
| 2 | Yang J, Li J, Tan R, et al. Protocatechualdehyde attenuates obstructive nephropathy through inhibiting lncRNA9884 induced inflammation. Phytother Res 2021; 35: 1521-33. |
| 3 | Schwenk MH, Hirsch JS, Bomback AS. Aldosterone blockade in CKD: emphasis on pharmacology. Adv Chronic Kidney Dis 2015; 22: 123-32. |
| 4 | Young MJ. Mechanisms of mineralocorticoid receptor-mediated cardiac fibrosis and vascular inflammation. Curr Opin Nephrol Hypertens 2008; 17: 174-80. |
| 5 | Belden Z, Deiuliis JA, Dobre M, Rajagopalan S. The role of the mineralocorticoid receptor in inflammation: focus on kidney and vasculature. Am J Nephrol 2017; 46: 298-314. |
| 6 | Lieber GB, Fernandez X, Mingo GG, et al. Mineralocorticoid receptor antagonists attenuate pulmonary inflammation and bleomycin-evoked fibrosis in rodent models. Eur J Pharmacol 2013; 718: 290-8. |
| 7 | Joffe HV, Adler GK. Effect of aldosterone and mineralocorticoid receptor blockade on vascular inflammation. Heart Fail Rev 2005; 10: 31-7. |
| 8 | Del Vecchio L, Procaccio M, Vigano S, Cusi D. Mechanisms of disease: the role of aldosterone in kidney damage and clinical benefits of its blockade. Nat Clin Pract Nephrol 2007; 3: 42-9. |
| 9 | Eddy AA. The origin of scar-forming kidney myofibroblasts. Nat Med 2013; 19: 964-6. |
| 10 | LeBleu VS, Taduri G, O'Connell J, et al. Origin and function of myofibroblasts in kidney fibrosis. Nat Med 2013; 19: 1047-53. |
| 11 | Nikolic-Paterson DJ, Wang S, Lan HY. Macrophages promote renal fibrosis through direct and indirect mechanisms. Kidney Int Suppl (2011) 2014; 4: 34-8. |
| 12 | Wang S, Meng XM, Ng YY, et al. TGF-beta/Smad3 signalling regulates the transition of bone marrow-derived macrophages into myofibroblasts during tissue fibrosis. Oncotarget 2016; 7: 8809-22. |
| 13 | Wang CH, Wang Z, Liang LJ, et al. The inhibitory effect of eplerenone on cell proliferation in the contralateral kidneys of rats with unilateral ureteral obstruction. Nephron 2017; 136: 328-38. |
| 14 | Xiong Y, Chang Y, Hao J, et al. Eplerenone attenuates fibrosis in the contralateral kidney of UUO rats by preventing macrophage-to-myofibroblast transition. Front Pharmacol 2021; 12: 620433. |
| 15 | Xu QY, Han L, Qin JG, et al. Zhao Yuyong's pathogenesis theory and clinical application of "kidney collateral stasis". Zhong Guo Zhong Yi Yao Za Zhi 2010; 25: 702-04. |
| 16 | Zhang Y, Hao J, Ma X, et al. Huoxue Jiedu Huayu recipe ameliorates mesangial cell pyroptosis in contralateral kidney of UUO Rats. Evid Based Complement Alternat Med 2020; 2020: 2530431. |
| 17 | Ranjit S, Dvornikov A, Levi M, Furgeson S, Gratton E. Characterizing fibrosis in UUO mice model using multiparametric analysis of phasor distribution from FLIM images. Biomed Opt Express 2016; 7: 3519-30. |
| 18 | Fan HY, Yang MY, Qi D, et al. Salvianolic acid A as a multifunctional agent ameliorates doxorubicin-induced nephropathy in rats. Sci Rep 2015; 5: 12273. |
| 19 | Li L, Shen Y, Ding Y, Liu Y, Su D, Liang X. Hrd1 participates in the regulation of collagen I synthesis in renal fibrosis. Mol Cell Biochem 2014; 386: 35-44. |
| 20 | Wynn TA, Barron L. Macrophages: master regulators of inflammation and fibrosis. Semin Liver Dis 2010; 30: 245-57. |
| 21 | Martin-Fernandez B, Rubio-Navarro A, Cortegano I, et al. Aldosterone induces renal fibrosis and inflammatory M1-Macrophage subtype via mineralocorticoid receptor in rats. PLoS One 2016; 11: e0145946. |
| 22 | Wang YY, Jiang H, Pan J, et al. Macrophage-to-myofibroblast transition contributes to interstitial fibrosis in chronic renal allograft injury. J Am Soc Nephrol 2017; 28: 2053-67. |
| 23 | Sun JY, Li C, Shen ZX, et al. Mineralocorticoid receptor deficiency in macrophages inhibits neointimal hyperplasia and suppresses macrophage inflammation through SGK1-AP1/NF-kappa B pathways. Arterioscler Thromb Vasc Biol 2016; 36: 874-85. |
| 24 | Chevalier RL. Obstructive nephropathy: lessons from cystic kidney disease. Nephron 2000; 84: 6-12. |
| 25 | Ma X, Chang Y, Xiong Y, Wang Z, Wang X, Xu Q. Eplerenone ameliorates cell pyroptosis in contralateral kidneys of rats with unilateral ureteral obstruction. Nephron 2019; 142: 233-42. |
| 26 | Navaneethan SD, Nigwekar SU, Sehgal AR, Strippoli GF. Aldosterone antagonists for preventing the progression of chronic kidney disease: a systematic review and Meta-analysis. Clin J Am Soc Nephrol 2009; 4: 542-51. |
| 27 | Shrestha A, Che RC, Zhang AH. Role of aldosterone in renal fibrosis. Adv Exp Med Biol 2019; 1165: 325-46. |
| 28 | Feng Y, Wang Q, Wang Y, Yard B, Lang F. SGK1-mediated fibronectin formation in diabetic nephropathy. Cell Physiol Biochem 2005; 16: 237-44. |
| 29 | Lang F, Voelkl J. Therapeutic potential of serum and glucocorticoid inducible kinase inhibition. Expert Opin Investig Drugs 2013; 22: 701-14. |
/
| 〈 |
|
〉 |